ÜSKÜDAR CANSU, D. Et Al. 2018. How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?. CLINICAL RHEUMATOLOGY , vol.37, no.12 , 3419-3425.

ÜSKÜDAR CANSU, D., ÜSKÜDAR TEKE, H., Bodakci, E., & KORKMAZ, C., (2018). How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?. CLINICAL RHEUMATOLOGY , vol.37, no.12, 3419-3425.

ÜSKÜDAR CANSU, DÖNDÜ Et Al. "How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?," CLINICAL RHEUMATOLOGY , vol.37, no.12, 3419-3425, 2018

ÜSKÜDAR CANSU, DÖNDÜ Ü. Et Al. "How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?." CLINICAL RHEUMATOLOGY , vol.37, no.12, pp.3419-3425, 2018

ÜSKÜDAR CANSU, D. Et Al. (2018) . "How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?." CLINICAL RHEUMATOLOGY , vol.37, no.12, pp.3419-3425.

@article{article, author={DÖNDÜ ÜSKÜDAR CANSU Et Al. }, title={How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?}, journal={CLINICAL RHEUMATOLOGY}, year=2018, pages={3419-3425} }